Annual Shareholders Equity
$155.55 M
-$1.63 M-1.03%
December 1, 2024
Summary
- As of March 13, 2025, ACRS annual stockholders equity is $155.55 million, with the most recent change of -$1.63 million (-1.03%) on December 1, 2024.
- During the last 3 years, ACRS annual shareholders equity has fallen by -$41.79 million (-21.18%).
- ACRS annual shareholders equity is now -30.95% below its all-time high of $225.26 million, reached on December 31, 2017.
Performance
ACRS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$155.55 M
+$25.40 M+19.52%
December 1, 2024
Summary
- As of March 13, 2025, ACRS quarterly stockholders equity is $155.55 million, with the most recent change of +$25.40 million (+19.52%) on December 1, 2024.
- Over the past year, ACRS quarterly shareholders equity has dropped by -$1.63 million (-1.03%).
- ACRS quarterly shareholders equity is now -36.32% below its all-time high of $244.26 million, reached on September 30, 2017.
Performance
ACRS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ACRS Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.0% | -1.0% |
| 3 y3 years | -21.2% | -21.2% |
| 5 y5 years | +122.5% | +167.4% |
ACRS Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -21.3% | at low | -34.0% | +19.5% |
| 5 y | 5-year | -21.3% | +313.2% | -34.0% | +313.2% |
| alltime | all time | -30.9% | +849.5% | -36.3% | +508.1% |
Aclaris Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $155.55 M(-1.0%) | $155.55 M(+19.5%) |
| Sep 2024 | - | $130.15 M(-2.7%) |
| Jun 2024 | - | $133.82 M(-5.8%) |
| Mar 2024 | - | $142.01 M(-9.6%) |
| Dec 2023 | $157.18 M(-20.5%) | $157.18 M(+0.5%) |
| Sep 2023 | - | $156.33 M(-13.0%) |
| Jun 2023 | - | $179.75 M(+1.7%) |
| Mar 2023 | - | $176.81 M(-10.5%) |
| Dec 2022 | $197.62 M(+0.1%) | $197.62 M(-10.1%) |
| Sep 2022 | - | $219.84 M(-6.8%) |
| Jun 2022 | - | $235.75 M(+30.8%) |
| Mar 2022 | - | $180.20 M(-8.7%) |
| Dec 2021 | $197.34 M(+424.1%) | $197.34 M(-8.9%) |
| Sep 2021 | - | $216.58 M(-7.4%) |
| Jun 2021 | - | $233.81 M(+108.2%) |
| Mar 2021 | - | $112.29 M(+198.3%) |
| Dec 2020 | $37.65 M(-46.1%) | $37.65 M(-7.6%) |
| Sep 2020 | - | $40.76 M(-17.4%) |
| Jun 2020 | - | $49.37 M(-15.1%) |
| Mar 2020 | - | $58.17 M(-16.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $69.91 M(-67.5%) | $69.91 M(-18.0%) |
| Sep 2019 | - | $85.28 M(-37.9%) |
| Jun 2019 | - | $137.23 M(-24.7%) |
| Mar 2019 | - | $182.25 M(-15.3%) |
| Dec 2018 | $215.12 M(-4.5%) | $215.12 M(+47.0%) |
| Sep 2018 | - | $146.33 M(-16.0%) |
| Jun 2018 | - | $174.20 M(-13.1%) |
| Mar 2018 | - | $200.47 M(-11.0%) |
| Dec 2017 | $225.26 M(+32.9%) | $225.26 M(-7.8%) |
| Sep 2017 | - | $244.26 M(+45.3%) |
| Jun 2017 | - | $168.14 M(+4.9%) |
| Mar 2017 | - | $160.29 M(-5.4%) |
| Dec 2016 | $169.49 M(+83.2%) | $169.49 M(+108.9%) |
| Sep 2016 | - | $81.12 M(-10.1%) |
| Jun 2016 | - | $90.24 M(+8.4%) |
| Mar 2016 | - | $83.21 M(-10.1%) |
| Dec 2015 | $92.52 M(-545.8%) | $92.52 M(-342.7%) |
| Sep 2015 | - | -$38.12 M(-453.1%) |
| Jun 2015 | - | $10.80 M(-152.0%) |
| Dec 2014 | -$20.75 M(+126.5%) | -$20.75 M |
| Dec 2013 | -$9.16 M | - |
FAQ
- What is Aclaris Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Aclaris Therapeutics?
- What is Aclaris Therapeutics annual shareholders equity year-on-year change?
- What is Aclaris Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Aclaris Therapeutics?
- What is Aclaris Therapeutics quarterly shareholders equity year-on-year change?
What is Aclaris Therapeutics annual stockholders equity?
The current annual shareholders equity of ACRS is $155.55 M
What is the all time high annual shareholders equity for Aclaris Therapeutics?
Aclaris Therapeutics all-time high annual stockholders equity is $225.26 M
What is Aclaris Therapeutics annual shareholders equity year-on-year change?
Over the past year, ACRS annual stockholders equity has changed by -$1.63 M (-1.03%)
What is Aclaris Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of ACRS is $155.55 M
What is the all time high quarterly shareholders equity for Aclaris Therapeutics?
Aclaris Therapeutics all-time high quarterly stockholders equity is $244.26 M
What is Aclaris Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, ACRS quarterly stockholders equity has changed by -$1.63 M (-1.03%)